|
Biogen Pharmachem Industries Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
43.17 Cr.
|
P/BV
|
0.44
|
Book Value (Rs.)
|
0.94
|
|
52 Week High/Low (Rs.)
|
1/0
|
FV/ML
|
1/1
|
P/E(X)
|
50.62
|
|
Bookclosure
|
15/05/2026
|
EPS (Rs.)
|
0.01
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.01 | 0.00 | 0.03 | 0.01 | 0.00 |
| Diluted EPS (Rs.) | 0.01 | 0.00 | 0.03 | 0.01 | 0.00 |
| Cash EPS (Rs.) | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.10 | 1.41 | 0.86 | 0.83 | 0.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.10 | 1.41 | 0.86 | 0.83 | 0.82 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| PBDIT / Share (Rs.) | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 |
| PBIT / Share (Rs.) | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 |
| PBT / Share (Rs.) | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 |
| Net Profit / Share (Rs.) | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | -0.34 |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | -0.34 |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | -0.34 |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | -0.34 |
| Return on Networth / Equity (%) | 0.86 | -0.31 | 3.41 | 0.83 | -0.01 |
| Return on Capital Employeed (%) | 0.96 | -0.31 | 3.41 | 0.83 | -0.01 |
| Return On Assets (%) | 0.86 | -0.31 | 3.39 | 0.83 | -0.01 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.27 | 29.65 | 0.30 | 0.64 | 2.37 |
| Quick Ratio (X) | 2.27 | 29.65 | 0.30 | 0.64 | 2.37 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | -46.77 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | 0.00 | 0.00 | -46.77 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 45.71 | 60.63 | 69.16 | 38.37 | 91.28 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 36.89 |
| EV / EBITDA (X) | 47.77 | -207.15 | 35.82 | 84.25 | -10849.12 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 36.93 |
| Price / BV (X) | 0.46 | 0.68 | 1.22 | 0.70 | 1.69 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 36.94 |
| EarningsYield | 0.01 | 0.00 | 0.02 | 0.01 | 0.00 |
